Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 16518588)

1.

Epigenetic modulation of intestinal cholesterol transporter Niemann-Pick C1-like 1 (NPC1L1) gene expression by DNA methylation.

Malhotra P, Soni V, Kumar A, Anbazhagan AN, Dudeja A, Saksena S, Gill RK, Dudeja PK, Alrefai WA.

J Biol Chem. 2014 Aug 15;289(33):23132-40. doi: 10.1074/jbc.M113.546283. Epub 2014 Jun 5.

PMID:
24904062
2.

Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes.

Ichimori S, Shimoda S, Goto R, Matsuo Y, Maeda T, Furukawa N, Kawashima J, Kodama S, Sekigami T, Isami S, Nishida K, Araki E.

J Diabetes Investig. 2012 Mar 28;3(2):179-84. doi: 10.1111/j.2040-1124.2011.00147.x.

3.

Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men.

Kakuda H, Kobayashi J, Nakato M, Takekoshi N.

Cholesterol. 2013;2013:314170. doi: 10.1155/2013/314170. Epub 2013 Dec 10.

4.

Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.

Bardini G, Rotella CM, Giannini S.

Rev Diabet Stud. 2012 Summer-Fall;9(2-3):82-93. doi: 10.1900/RDS.2012.9.82. Epub 2012 Nov 15. Review.

5.

D-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation.

Malhotra P, Boddy CS, Soni V, Saksena S, Dudeja PK, Gill RK, Alrefai WA.

Am J Physiol Gastrointest Liver Physiol. 2013 Jan 15;304(2):G203-10. doi: 10.1152/ajpgi.00288.2012. Epub 2012 Nov 8.

6.

Recent advances in small bowel diseases: Part II.

Thomson AB, Chopra A, Clandinin MT, Freeman H.

World J Gastroenterol. 2012 Jul 14;18(26):3353-74. doi: 10.3748/wjg.v18.i26.3353. Review.

7.

The chylomicron: relationship to atherosclerosis.

Tomkin GH, Owens D.

Int J Vasc Med. 2012;2012:784536. doi: 10.1155/2012/784536. Epub 2011 Oct 5.

8.

SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin.

Kumar P, Malhotra P, Ma K, Singla A, Hedroug O, Saksena S, Dudeja PK, Gill RK, Alrefai WA.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G148-55. doi: 10.1152/ajpgi.00119.2011. Epub 2011 Apr 28.

9.

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P.

J Lipid Res. 2011 Mar;52(3):558-65. doi: 10.1194/jlr.M011080. Epub 2010 Dec 1.

10.

Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Masson CJ, Plat J, Mensink RP, Namiot A, Kisielewski W, Namiot Z, F├╝llekrug J, Ehehalt R, Glatz JF, Pelsers MM.

PLoS One. 2010 Apr 29;5(4):e10380. doi: 10.1371/journal.pone.0010380.

11.

NPC1L1 and cholesterol transport.

Betters JL, Yu L.

FEBS Lett. 2010 Jul 2;584(13):2740-7. doi: 10.1016/j.febslet.2010.03.030. Epub 2010 Mar 19. Review.

12.

Protein mediators of sterol transport across intestinal brush border membrane.

Brown JM, Yu L.

Subcell Biochem. 2010;51:337-80. doi: 10.1007/978-90-481-8622-8_12. Review.

13.

Molecular processes that handle -- and mishandle -- dietary lipids.

Williams KJ.

J Clin Invest. 2008 Oct;118(10):3247-59. doi: 10.1172/JCI35206. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk